Literature DB >> 2191877

A duplex criterion for aorto-iliac stenosis.

A A de Smet1, P J Kitslaar.   

Abstract

Duplex scanning is a new non-invasive test, which enables direct evaluation of aorto-iliac stenoses. The usual duplex criterion for an arterial stenosis is local increase in peak systolic velocity. For haemodynamically significant aorto-iliac stenoses a threshold value for this increase has not yet been established. In order to define a duplex criterion for significant aorto-iliac disease. The whole segment was scanned to locate areas with high peak systolic velocities which were then compared to the velocities recorded immediately up and downstream. The value of the highest proportional velocity change was used as the criterion for duplex classification of the segment. Duplex results were compared to the outcome of invasive femoral artery pressure measurements combined with reactive hyperaemia (FAP test). For a range of threshold values of the duplex criterion the specificity and sensitivity was calculated using the FAP test as the gold standard (R.O.C. analysis). The combinations of the highest sensitivity and specificity were obtained in the range of 100-200% change in peak systolic velocity as duplex criteria for significant aorto-iliac stenosis. The highest accuracy (88%) was obtained at a 200% change in the peak systolic velocity.

Entities:  

Mesh:

Year:  1990        PMID: 2191877     DOI: 10.1016/s0950-821x(05)80207-5

Source DB:  PubMed          Journal:  Eur J Vasc Surg        ISSN: 0950-821X


  2 in total

1.  The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: a prospective study.

Authors:  B H Elsman; D A Legemate; F W van der Heyden; H de Vos; W P Mali; B C Eikelboom
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Sep-Oct       Impact factor: 2.740

2.  Iso-osmotic bowel preparation improves the accuracy of iliac artery colour flow duplex examination.

Authors:  M S Whiteley; A D Fox; R A Harris; M Horrocks
Journal:  J R Soc Med       Date:  1995-11       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.